Cumberland Pharmaceuticals Incorporation operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cumberland Pharmaceuticals Incorporation with three other
companies in this sector in UNITED STATES :
Harrow Health Inc
sales of $51.17 million
of which 100%
was Pharmaceutical Compounding),
Integrated Biopharma, Inc.
of which 100%
was Creating and commercializing products).
Cumberland Pharmaceuticals Incorporation reported sales of $47.53 million
December of 2019.
increase of 16.7%
versus 2018, when the company's sales were $40.74 million.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
266.2% in 2019, from
$540,933.00 to $1.98 million.
Cumberland Pharmaceuticals Incorporation also saw significant increases in sales in
Vibativ (up 71.3% to $8.69 million)
Omeclamox-Pak (up 34.4% to $837,829.00 )
Not all segments of Cumberland Pharmaceuticals Incorporation experienced an increase in sales in 2019:
sales of Totect fell 56.5% to $369,912.00 .
(However, this segment's sales were only a very small portion of the company's overall sales).
Cumberland Pharmaceuticals Incorporation also experienced decreases in sales in
Acetadote (down 10.7% to $3.82 million)
Vaprisol (down 46.9% to $936,615.00 )